Small businesses are struggling with rising costs and tariffs, but many are still looking to maintain or increase health coverage, according to a recent report from Chase.

Novo Nordisk’s GLP-1 drug Wegovy expanded its label to include the metabolic disorder known as MASH. Analysts say there’s ...

A new Trilliant Health report reveals vast price variation for identical healthcare services, even for procedures delivered at the exact same facility. Allison Oakes, Trilliant’s chief research ...

Here are five guidelines to help employers balance health outcomes and financial responsibility to ensure that GLP-1 coverage is effective, affordable, and aligned with improved health and ...

Hospital margins improved in June as revenue gains outpaced patient volume — but Kaufman Hall’s latest data shows that financial gaps between high- and low-performing organizations persist, with ...

Noom recently launched a microdosing program for GLP-1s. However, some are concerned about the use of compounded GLP-1s in this program, as they are not FDA-approved.

Even with venture capital fundraising slowing down, Hatteras Venture Partners was able to close two new funds for investments in seed- and early-stage companies. We also have a recap of recent ...

Health plan sponsors have more flexibility and opportunities than before to improve healthcare access and steer their workforce toward high-quality, high-value care.

We must continuously improve our education system, spanning from classroom to continued education, with vetted techniques that acknowledge the chaos and complexity of the healthcare environment ...

Employers are projecting a median 10% increase in healthcare costs for 2026, driven largely by high claims and specialty drug ...

Some large health systems are experimenting with selling their internal capabilities — such as IT support, revenue cycle management and call center operations — to smaller hospitals as a new ...